CME Group Inc (CME) is slightly overvalued and Moody's Corp (MCO) is overvalued.
Both trade above our estimate of their intrinsic value. CME is the closer of the two: -15%, against -63% for MCO.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $232.06; the price of $267.21 is 15% above that value, and 82% of that value comes from beyond year five.
Leak Score 61/100 on 8 of 12 signals
Discounting its cash flows at 10.7% (average of 3 methods) values the shares at $287.91; the price of $469.25 is 63% above that value, and 71% of that value comes from beyond year five.
Leak Score 65/100 on 10 of 12 signals
| Metric | CME | MCO |
|---|---|---|
| Verdict | Slightly overvalued | Overvalued |
| Price | $267.21 | $469.25 |
| Intrinsic value | $232.06 | $287.91 |
| Margin of safety | -15% | -63% |
| Leak Score | 61/100 (8/12) | 65/100 (10/12) |
| Market cap | $96.1B | $81.3B |
| Revenue growth, 5 years | 6.0% | 7.5% |
| Operating margin | 65.1% | 46.0% |
| Net margin | 63.1% | 34.3% |
| Return on equity | 15.8% | 80.2% |
| Debt to equity | 0.15 | 2.49 |
| P/E | 22.7x | 29.8x |
| Forward P/E | 20.7x | 24.8x |
| P/B | 3.6x | 26.9x |
| Dividend yield | 4.3% | 0.8% |